Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

DADA2: High–resolution sample inference from Illumina amplicon data

Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · see citing works

Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy

Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,770 · see citing works

Human gut microbiome viewed across age and geography

Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815 · see citing works

Gut metagenome in European women with normal, impaired and diabetic glucose control

Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · see citing works

Environment dominates over host genetics in shaping human gut microbiota

Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P. I., Godneva, A., Kalka, I. N., Bar, N., et al. (2018) · Nature · doi:10.1038/nature25973 · Cited by 2,859 · see citing works

Population-level analysis of gut microbiome variation

Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400 · see citing works

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116 · see citing works

<i>Akkermansia muciniphila</i> and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology

Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., Kayser, B. D., Levenez, F., Chilloux, J., Hoyles, L., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308778 · Cited by 1,931 · see citing works

Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity

Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A. V., Falony, G., Vieira-Silva, S., et al. (2016) · Science · doi:10.1126/science.aad3369 · Cited by 1,914 · see citing works

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632 · see citing works

Obesity and Severe Obesity Forecasts Through 2030

Finkelstein, E. A., Khavjou, O., Thompson, H. F., Trogdon, J. G., Pan, L., Sherry, B., & Dietz, W. H. (2012) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.10.026 · Cited by 1,418 · see citing works

Reliability and relative validity of an FFQ for nutrients in the Tehran Lipid and Glucose Study

Mirmiran, P., Hosseini Esfahani, F., Mehrabi, Y., Hedayati, M., & Azizi, F. (2010) · Public Health Nutrition · doi:10.1017/s1368980009991698 · Cited by 1,292 · see citing works

Host-Derived Nitrate Boosts Growth of <i>E. coli</i> in the Inflamed Gut

Winter, S. E., Winter, M. G., Xavier, M. N., Thiennimitr, P., Poon, V., Keestra, A. M., Laughlin, R. C., Gomez, G., Wu, J., Lawhon, S. D., et al. (2013) · Science · doi:10.1126/science.1232467 · Cited by 1,019 · see citing works

Reproducibility and Relative Validity of Food Group Intake in a Food Frequency Questionnaire Developed for the Tehran Lipid and Glucose Study

Hosseini Esfahani, F., Asghari, G., Mirmiran, P., & Azizi, F. (2010) · Journal of Epidemiology · doi:10.2188/jea.je20090083 · Cited by 880 · see citing works

Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics

Holmes, I. H., Harris, K. J., & Quince, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030126 · Cited by 834 · see citing works

Roseburia Spp.: A Marker of Health?

Tamanai‐Shacoori, Z., Smida, I., Bousarghin, L., Loréal, O., Meuric, V., Fong, S. B., Bonnaure‐Mallet, M., & Jolivet‐Gougeon, A. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0130 · Cited by 751 · see citing works

Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading <i>Akkermansia muciniphila</i> and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut

de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S. (2017) · Diabetes Care · doi:10.2337/dc16-1324 · Cited by 704 · see citing works

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats

Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., & Zhao, L. (2015) · Scientific Reports · doi:10.1038/srep14405 · Cited by 630 · see citing works

Individual diet has sex-dependent effects on vertebrate gut microbiota

Bolnick, D. I., Snowberg, L. K., Hirsch, P. E., Lauber, C. L., Org, E., Parks, B. W., Lusis, A. J., Knight, R. D., Caporaso, J. G., & Svanbäck, R. (2014) · Nature Communications · doi:10.1038/ncomms5500 · Cited by 598 · see citing works

Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update

Piché, M.-E., Poirier, P., Lemieux, I., & Després, J.-P. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.06.004 · Cited by 558 · see citing works

Sex, body mass index, and dietary fiber intake influence the human gut microbiome

Dominianni, C., Sinha, R., Goedert, J. J., Pei, Z., Yang, L., Hayes, R. B., & Ahn, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124599 · Cited by 468 · see citing works

Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial

Tong, X., Xu, J. Y., Lian, F., Yu, X., Zhao, Y., Xu, L., Zhang, M. H., Zhao, X., Shen, J., Wu, S., et al. (2018) · mBio · doi:10.1128/mbio.02392-17 · Cited by 376 · see citing works

Gut Commensal E. coli Proteins Activate Host Satiety Pathways following Nutrient-Induced Bacterial Growth

Breton, J., Tennoune, N., Lucas, N., Francois, M., Legrand, R., Jacquemot, J., Goichon, A., Guérin, C., Peltier, J., Pestel-Caron, M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.017 · Cited by 321 · see citing works

A taxonomic signature of obesity in a large study of American adults

Peters, B. A., Shapiro, J. A., Church, T. R., Miller, G., Trinh‐Shevrin, C., Yuen, E., Friedlander, C., Hayes, R. B., & Ahn, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-28126-1 · Cited by 315 · see citing works

LotuS: an efficient and user-friendly OTU processing pipeline

Hildebrand, F., Tadeo, R., Voigt, A. Y., Peer Bork, B., & Raes, J. (2014) · Microbiome · doi:10.1186/2049-2618-2-30 · Cited by 307 · see citing works

The gut microbiome in obesity

Tseng, C.-H., & Wu, C. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.07.009 · Cited by 278 · see citing works

Brief Report: Dialister as a Microbial Marker of Disease Activity in Spondyloarthritis

Tito, R. Y., Cypers, H., Joossens, M., Varkas, G., Praet, L. V., Glorieus, E., den Bosch, F. E. V., Vos, M. D., Raes, J., & Elewaut, D. S. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39802 · Cited by 277 · see citing works

Prevotella-to-Bacteroides ratio predicts body weight and fat loss success on 24-week diets varying in macronutrient composition and dietary fiber: results from a post-hoc analysis

Hjorth, M. F., Blædel, T., Bendtsen, L. Q., Lorenzen, J. K., Holm, J. B., Kiilerich, P., Roager, H. M., Kristiansen, K., Larsen, L. H., & Astrup, A. V. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0093-2 · Cited by 262 · see citing works

Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity

Seifarth, C., Schehler, B., & Schneider, H. (2012) · Experimental and Clinical Endocrinology &amp; Diabetes · doi:10.1055/s-0032-1327734 · Cited by 258 · see citing works

Heritable components of the human fecal microbiome are associated with visceral fat

Beaumont, M., Goodrich, J. K., Jackson, M. A., Yet, İ., Davenport, E., Vieira‐Silva, S., Debelius, J. W., Pallister, T., Mangino, M., Raes, J., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1052-7 · Cited by 239 · see citing works

Effects of metformin on weight loss: potential mechanisms

Malin, S. K., & Kashyap, S. R. (2014) · Current Opinion in Endocrinology, Diabetes &amp; Obesity · doi:10.1097/med.0000000000000095 · Cited by 223 · see citing works

Microbial Enterotypes, Inferred by the Prevotella-to-Bacteroides Ratio, Remained Stable during a 6-Month Randomized Controlled Diet Intervention with the New Nordic Diet

Roager, H. M., Licht, T. R., Poulsen, S. K., Larsen, T. M., & Bahl, M. I. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03549-13 · Cited by 194 · see citing works

Prevalence of obesity and overweight in adults and children in Iran; a systematic review

Jafari-Adli, S., Jouyandeh, Z., Qorbani, M., Soroush, A., Larijani, B. A., & Hasani‐Ranjbar, S. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0121-2 · Cited by 184 · see citing works

Epidemiology of Obesity and Associated Comorbidities

Andolfi, C., & Fisichella, P. M. (2018) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2018.0380 · Cited by 167 · see citing works

Consumption of Two Healthy Dietary Patterns Restored Microbiota Dysbiosis in Obese Patients With Metabolic Dysfunction

Haro, C., García‐Carpintero, S., Rangel‐Zúñiga, O. A., Alcalá‐Díaz, J. F., Landa, B. B., Clemente, J. C., Pérez‐Martínez, P., López‐Miranda, J., Pérez‐Jiménez, F., & Camargo, A. (2017) · Molecular Nutrition &amp; Food Research · doi:10.1002/mnfr.201700300 · Cited by 149 · see citing works

Effects of Antidiabetic Drugs on Gut Microbiota Composition

Montandon, S., & Jornayvaz, F. (2017) · Genes · doi:10.3390/genes8100250 · Cited by 135 · see citing works

Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents

Ejtahed, H., Soroush, A. R., Angoorani, P., Larijani, B. A., & Hasani‐Ranjbar, S. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-107792 · Cited by 113 · see citing works

Metformin

Rodriguez, J., Hiel, S., & Delzenne, N. M. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000468 · Cited by 113 · see citing works

Environment dominates over host genetics in shaping human gut microbiota

Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P. I., Godneva, A., Kalka, I. N., & Bar, N. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.14.5 · Cited by 90 · see citing works

Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults

Malin, S. K., Nightingale, J., Choi, S., Chipkin, S. R., & Braun, B. (2013) · Obesity · doi:10.1002/oby.20235 · Cited by 88 · see citing works

Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling

Rosário, D., Benfeitas, R., Bidkhori, G., Zhang, C., Uhlén, M., Shoaie, S., & Mardinoğlu, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00775 · Cited by 85 · see citing works

Obesity and Severe Obesity Forecasts Through 2030

(2012) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(12)00266-8 · Cited by 72 · see citing works

Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes

Mardinoğlu, A., Borén, J., & Smith, U. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.012 · Cited by 69 · see citing works

Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis

Graff, S. K., Mario, F. M., Ziegelmann, P., & Spritzer, P. M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12787 · Cited by 63 · see citing works

Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis

Ma, W., Chen, J., Meng, Y., Yang, J., Cui, Q., & Zhou, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01336 · Cited by 63 · see citing works

Heritable components of the human fecal microbiome are associated with visceral fat

Roy, C. I. L., Beaumont, M., Jackson, M. A., Steves, C. J., Spector, T. D., & Bell, J. T. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1356556 · Cited by 61 · see citing works

Adaptation of human gut microbiota to bariatric surgeries in morbidly obese patients: A systematic review

Ejtahed, H., Angoorani, P., Hasani‐Ranjbar, S., Siadat, S. D., Ghasemi, N., Larijani, B. A., & Soroush, A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.12.074 · Cited by 59 · see citing works

Gender-specific Effects of Treatment with Lifestyle, Metformin or Sulfonylurea on Glycemic Control and Body Weight: A German Multicenter Analysis on 9 108 Patients

Schütt, M., Zimmermann, A., Hood, R., Hummel, M., Seufert, J., Siegel, E. G., Tytko, A., Holl, R. W., & for the DPV initiative and the German BMBF Competence Network Diabetes mellitus (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1559608 · Cited by 41 · see citing works

Ondansetron and Metformin-Induced Gastrointestinal Side Effects

Hoffmann, I., Roa, M., Torrico, F., & Cubeddu, L. X. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200311000-00012 · Cited by 37 · see citing works

Human Microbiome as an Approach to Personalized Medicine.

Ejtahed, H., Hasani‐Ranjbar, S., & Larijani, B. A. (2017) · PubMed · Cited by 36 · see citing works

Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis

Maniar, K., Moideen, A., Bhattacharyya, R., & Banerjee, D. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.06.001 · Cited by 23 · see citing works

Metformin Modifies the Exercise Training Effects on Risk Factors for Cardiovascular Disease in Impaired Glucose Tolerant Adults

Malin, S. K., Nightingale, J., Choi, S.-E., Chipkin, S. R., & Braun, B. (2012) · Obesity · doi:10.1038/oby.2012.133 · Cited by 11 · see citing works

Primary care management of obesity

Hensley, R. D. (2018) · The Nurse Practitioner · doi:10.1097/01.npr.0000534941.27466.0b · Cited by 5 · see citing works

Gut microbiota in the pathogenesis and therapeutic approaches of diabetes

Crudele, L., Gadaleta, R. M., Cariello, M., & Moschetta, A. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104821 · Cited by 251 · see citing works

The influence of the gut microbiota on the bioavailability of oral drugs

Zhang, X., Han, Y., Huang, W., Jin, M., & Gao, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.013 · Cited by 246 · see citing works

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus

Zhang, Q., & Hu, N. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s286430 · Cited by 185 · see citing works

Considering gut microbiota in treatment of type 2 diabetes mellitus

Adeshirlarijaney, A., & Gewirtz, A. T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1717719 · Cited by 158 · see citing works

Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes

Huda, M. N., Kim, M., & Bennett, B. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632335 · Cited by 129 · see citing works

The association of weight loss with changes in the gut microbiota diversity, composition, and intestinal permeability: a systematic review and meta-analysis

Koutoukidis, D. A., Jebb, S. A., Zimmerman, M., Otunla, A. A., Henry, J. A., Ferrey, A. E., Schofield, E., Kinton, J., Aveyard, P. N., & Marchesi, J. R. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2020068 · Cited by 123 · see citing works

Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice

Xue, J., Li, X., Liu, P., Li, K., Sha, L., Yang, X., Zhu, L., Wang, Z., Dong, Y., Zhang, L., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0567 · Cited by 107 · see citing works

Effects of metformin on the gut microbiota: A systematic review

Petakh, P., Kamyshna, I. I., & Kamyshnyi, O. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101805 · Cited by 105 · see citing works

Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults

Ejtahed, H., Tavassol, Z. H., Khatami, S., Zangeneh, M., Behrouzi, A., Badi, S. A., Moshiri, A., Hasani‐Ranjbar, S., Soroush, A., Vaziri, F., et al. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00502-7 · Cited by 62 · see citing works

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus

Liu, W., Luo, Z., Zhou, J., & Sun, B. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.853771 · Cited by 62 · see citing works

Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target

Ziqubu, K., Mazibuko-Mbeje, S. E., Mthembu, S. X. H., Mabhida, S. E., Jack, B. U., Nyambuya, T. M., Nkambule, B. B., Basson, A. K., Tiano, L., & Dludla, P. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032227 · Cited by 60 · see citing works

Direct and Indirect Evidence of Effects of Bacteroides spp. on Obesity and Inflammation

Wu, L., Park, S., & Kim, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010438 · Cited by 53 · see citing works

Risk Factors, Clinical Consequences, Prevention, and Treatment of Childhood Obesity

Shaban Mohamed, M. A., AbouKhatwa, M. M., Saifullah, A. A., Hareez Syahmi, M., Mosaad, M., Elrggal, M. E., Dehele, I. S., & Elnaem, M. H. (2022) · Children · doi:10.3390/children9121975 · Cited by 52 · see citing works

Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis

Huang, X., Hong, X., Wang, J., Sun, T., Yu, T., Yu, Y., Fang, J., & Xiong, H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103037 · Cited by 50 · see citing works

Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies

Cao, T. T. B., Wu, K., Hsu, J., Chang, C., Chou, C., Lin, C.-Y., Liao, Y.-M., Lin, P.-C., Yang, L., & Lin, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573891 · Cited by 49 · see citing works

Grape Polyphenols Attenuate Diet-Induced Obesity and Hepatic Steatosis in Mice in Association With Reduced Butyrate and Increased Markers of Intestinal Carbohydrate Oxidation

Mezhibovsky, E., Knowles, K. A., He, Q., Sui, K., Tveter, K. M., Duran, R. M., & Roopchand, D. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.675267 · Cited by 46 · see citing works

Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self

Litvak, Y., & Bäumler, A. J. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.003 · Cited by 43 · see citing works

Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments

García-Beltrán, C., Malpique, R., Carbonetto, B., González‐Torres, P., Henares, D., Brotons, P., Muñoz‐Almagro, C., López‐Bermejo, A., de Zegher, F., & Ibáñez, L. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12734 · Cited by 43 · see citing works

Our Little Friends with Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders

Ejtahed, H., Angoorani, P., Soroush, A., Siadat, S. D., Shirzad, N., Hasani‐Ranjbar, S., & Larijani, B. A. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190930110605 · Cited by 40 · see citing works

GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin

Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Peng, X., Chen, Y., & Routy, J.-P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.581839 · Cited by 39 · see citing works

Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome via regulating butyrate dependent gut–brain–ovary axis mechanism

Feng, X., Wang, D., Hu, L., Lu, H., Ling, B., Huang, Y., & Jiang, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962775 · Cited by 39 · see citing works

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

Zhang, K., Zhang, Q., Qiu, H., Ma, Y., Hou, N., Zhang, J., Kan, C., Han, F., Sun, X., & Shi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37609 · Cited by 39 · see citing works

Metformin, a biological and synthetic overview

Hernández‐Velázquez, E. D., Betancourt, C. A., Alonso‐Castro, Á. J., Ortíz‐Alvarado, R., López, J. A., Meza‐Carmen, V., & Solorio‐Alvarado, C. R. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129241 · Cited by 35 · see citing works

Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword

Petakh, P., Kamyshna, I. I., Nykyforuk, A., Yao, R., Imbery, J. F., Oksenych, V., Korda, M. M., & Kamyshnyi, O. (2022) · Viruses · doi:10.3390/v14030477 · Cited by 32 · see citing works

Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment

Petakh, P., Kamyshna, I. I., Oksenych, V., Kainov, D. E., & Kamyshnyi, O. (2023) · Pharmaceuticals · doi:10.3390/ph16060904 · Cited by 30 · see citing works

Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial

Molina‐Vega, M., César, M. J. P., Gutiérrez‐Repiso, C., Fernández‐Valero, A., Lima-Rubio, F., González‐Romero, S., Moreno‐Indias, I., & Tinahones, F. J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112465 · Cited by 29 · see citing works

Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study

Glaros, S. B., Mishra, S. P., Jain, S., Davis, F., Gabel, S. A., Mueller, G. A., Jarmusch, A. K., Mabundo, L. S., Courville, A. B., Walter, M. F., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2558071 · Cited by 30 · see citing works

Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes

Anwardeen, N. R., Naja, K., & Elrayess, M. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1506767 · Cited by 27 · see citing works

The Beneficial Effects of Lippia Citriodora Extract on Diet‐Induced Obesity in Mice Are Associated with Modulation in the Gut Microbiota Composition

Diez‐Echave, P., Vezza, T., Rodríguez‐Nogales, A., Hidalgo‐Garcia, L., Garrido‐Mesa, J., Ruiz‐Malagón, A. J., Molina‐Tijeras, J. A., Romero, M., Robles‐Vera, I., Leyva‐Jiménez, F. J., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000005 · Cited by 24 · see citing works

Evaluation of the gut microbiota after metformin intervention in children with obesity: A metagenomic study of a randomized controlled trial

Pastor‐Villaescusa, B., Plaza‐Díaz, J., Egea-Zorrilla, A., Leis, R., Bueno, G., Hoyos, R., Vázquez‐Cobela, R., Latorre-Millán, M., Cañete, M. D., Caballero‐Villarraso, J., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111117 · Cited by 22 · see citing works

Metformin-induced changes of the gut microbiota in patients with type 2 diabetes mellitus: results from a prospective cohort study

Gao, Y., Zhao, T., Lv, N., Liu, S., Yuan, T., Fu, Y., Zhao, W., & Zhu, B. (2024) · Endocrine · doi:10.1007/s12020-024-03828-x · Cited by 21 · see citing works

Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis

Huang, S., Ou, Y., Tang, K.-S., Yu, H., Huang, L., Tain, Y., Lin, I.-C., Sheen, J., Hou, C., Tsai, C., et al. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01521-w · Cited by 20 · see citing works

Gut microbiome: New perspectives for type 2 diabetes prevention and treatment

Li, S.-X., & Guo, Y. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i31.7508 · Cited by 20 · see citing works

Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes

Chu, N. H. S., Chan, J. C. N., & Chow, E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.857090 · Cited by 19 · see citing works

Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions

Proffitt, C., Bidkhori, G., Moyes, D. L., & Shoaie, S. (2020) · Microorganisms · doi:10.3390/microorganisms8091381 · Cited by 19 · see citing works

The landscape of microbiota research in Iran; a bibliometric and network analysis

Aazami, H., Dehghanbanadaki, H., Ejtahed, H., Fahimfar, N., Razi, F., Soroush, A., Hasani‐Ranjbar, S., Pasalar, P., Badi, S. A., Siadat, S. D., et al. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00488-2 · Cited by 16 · see citing works

Akkermansia, a Possible Microbial Marker for Poor Glycemic Control in Qataris Children Consuming Arabic Diet—A Pilot Study on Pediatric T1DM in Qatar

Lakshmanan, A. P., Kohil, A., Assadi, F. E., Zaidan, S. A., Alabduljabbar, S., Bangarusamy, D. K., Khalaf, F. A., Petrovski, G., & Terranegra, A. (2021) · Nutrients · doi:10.3390/nu13030836 · Cited by 16 · see citing works

Gut microbiota heterogeneity in non-alcoholic fatty liver disease: a narrative review of drivers, mechanisms, and clinical relevance

Guo, Y., Zhang, N., & Pei, D. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1645298 · Cited by 14 · see citing works

A diet high in FODMAPs as a novel dietary strategy in diabetes?

Chu, N. H. S., Chan, J. C. N., & Chow, E. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.036 · Cited by 15 · see citing works

Synthesis and in vivo Evaluation of Fluorobenzyl Metformin Derivatives as Potential Drugs in The Diabetes Treatment

Hernández‐Velázquez, E. D., Herrera, M. D., Betancourt, C. A., Navarro‐Santos, P., Ortíz‐Alvarado, R., & Solorio‐Alvarado, C. R. (2023) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202300200 · Cited by 11 · see citing works

Investigation of the probiotic supplement’s effect on obese adults demonstrated a reduction in fasting insulin levels: a double-blind randomized clinical trial

Hasani‐Ranjbar, S., Tavassol, Z. H., Malmir, H., Ejtahed, H., Ebrahimi, M. T., & Larijani, B. A. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01400-y · Cited by 11 · see citing works

Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial

the ABLE-MET Investigators, Ono, K., Wada, H., Satoh‐Asahara, N., Inoue, H., Uehara, K., Funada, J., Ogo, A., Horie, T., Fujita, M., et al. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00381-1 · Cited by 11 · see citing works

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial

El‐Khateeb, E., Elberri, E. I., Mosalam, E. M., Nooh, M. Z., Abdelsattar, S., Alghamdi, A. M., Alrubia, S., & Abdallah, M. S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1153653 · Cited by 11 · see citing works

Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis

Zhang, C., Sha, Y., Liu, H., Guo, D., Jiang, Y., Hong, L., Shi, L., & Huang, H. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.36 · Cited by 10 · see citing works

Serum Metabolome Mediates the Antiobesity Effect of Celastrol-Induced Gut Microbial Alterations

Xu, S., Lyu, L., Zhu, H., Huang, X., Xu, W., Xu, W., Feng, Y., & Fan, Y. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00513 · Cited by 9 · see citing works

Microbially catalyzed anode and cathode microbial electrosynthesis system for efficient metformin removal and volatile fatty acid production

Ali, A. S., Tahir, K., Kim, B., Lim, Y., & Lee, D. S. (2023) · Fuel · doi:10.1016/j.fuel.2023.130237 · Cited by 7 · see citing works

A Comprehensive Pilot Study to Elucidate the Distinct Gut Microbial Composition and Its Functional Significance in Cardio-Metabolic Disease

Ray, A. K., Shukla, A., Yadav, A., Kaur, U. S., Singh, A. K., Mago, P., Bhavesh, N. S., Chaturvedi, R., Tandon, R., Shalimar, S., et al. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10847-w · Cited by 7 · see citing works

Gut microbiome diversity measures for metabolic conditions: a systematic scoping reviewPreprint

Samuthpongtorn, C., Nopsopon, T., & Pongpirul, K. (2021) · medRxiv · doi:10.1101/2021.06.25.21259549 · Cited by 7 · see citing works

Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics

Garzon-Escamilla, N., Medina-Cardena, M., Roy, P., Trent, J., Jamous, J., Somesan, Y., & Denslow, S. (2026) · Biomedicines · doi:10.3390/biomedicines14020316 · Cited by 4 · see citing works

Microbiota research in Iran; current knowledge and future perspective

Ejtahed, H., Hasani‐Ranjbar, S., Soroush, A., Siadat, S. D., & Larijani, B. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00703-0 · Cited by 4 · see citing works

Bioactive compounds in diabetes care and prevention

Ahmed, M. N., Dable-Tupas, G., Rahmatullah, M., Ratta, K., Michael, M., & Ghosh, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824412-8.00014-x · Cited by 4 · see citing works

Overweight management: A cross-sectional study with special insight on metformin use in obesity control

Al-Qudah, S. A., Al-Hamaideh, K. D., Dmour, I. M., & Sbaihi, S. A. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.120818 · Cited by 3 · see citing works

Metformin hijacks AMPK-ERK1/2 signaling to trigger a pathogenic “selection trap” and thymic atrophy

Qian, Y., Zhang, J., Liu, S., & Qin, Y. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116762 · Cited by 1 · see citing works

The Therapeutic Optimization of the Gut Microbiota in Diabetes Management

Davidson, P., Davidson, D., Loesch, J., & Limgrover, A. (2020) · ADCES in Practice · doi:10.1177/2633559x20911730

Impact drugs targeting cardiometabolic risk on the gut microbiota

Balvers, M., van den Born, B. H., Levin, E., & Nieuwdorp, M. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000727

Multidimensional perspective of obesity; prevention to treatment

Ejtahed, H., Hasani‐Ranjbar, S., Soroush, A., & Larijani, B. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00705-y

Extracellular Vesicles Derived from Gastrointestinal Microbiota: A New Approach to Clinical Studies

Tavassol, Z. H., Marvasti, F. E., Hasani‐Ranjbar, S., Ejtahed, H., Siadat, S. D., & Larijani, B. A. (2021) · DOAJ (DOAJ: Directory of Open Access Journals)

Particularities of the intestinal microbiome composition in Romanian patients with metabolic syndrome and type 2 diabetes

Aron, R. A. C., Ţiţ, D. M., Moleriu, R. D., Vesa, C. M., BUNGAU, S., Tarce, A. G., Behl, T., & BUNGAU, S. G. (2021) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2021.56.4.04

How Does Metformin Work in the Treatment of Obesity? A Review

Shalahuddin, M. S., & Rahmawati, R. P. (2022) · doi:10.2991/978-94-6463-048-0_4

The Investigation into Correlation between Type 2 Diabetes Mellitus and the Gut Microbiota

Liu, S., & Zhu, A. M. (2025) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2025.1511022

Microbial Dysbiosis and Metabolic Disorder

Kesavardhini, K., Saranraj, P., Subhalakshmi, U., Gayathri, K., & Lokeshwari, B. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-4382-2.ch008

The impact of gut microbiota on insulin resistance in polycystic ovary syndrome: mechanisms and therapeutic prospects

Gao, Y., Liu, C., & He, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1840605

Predicting response to GLP-1–based therapy in MASLD/MASH: an evidence-tiered, endpoint-specific framework built on host genotype and gut microbial features

Zhu, G., Huang, Y., Huang, Y., & 杨文龙 (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1962068

Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial

Mueller, N. T., Differding, M. K., Zhang, M., Maruthur, N. M., Juraschek, S. P., Miller, E. R., Appel, L. J., & Yeh, H. (2021) · Diabetes Care · doi:10.2337/dc20-2257 · Cited by 220 · see citing works

Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults

Hibberd, A. A., Yde, C. C., Ziegler, M. L., Honoré, A. H., Saarinen, M., Lahtinen, S. J., Stahl, B., Jensen, H. M., & Stenman, L. K. (2018) · Beneficial Microbes · doi:10.3920/bm2018.0028 · Cited by 179 · see citing works

999-P: Liraglutide Treatment in Obese Diabetic Patients Modulates Gut Microbiota

Moffa, S., Tesori, V., Mezza, T., CEFALO, C. M. A., Cinti, F., Sorice, G. P., & Giaccari, A. (2019) · Diabetes · doi:10.2337/db19-999-p · Cited by 1 · see citing works

Link between gut microbiota and health outcomes in inulin -treated obese patients: Lessons from the Food4Gut multicenter randomized placebo-controlled trial

Hiel, S., Gianfrancesco, M. A., Rodriguez, J., Portheault, D., Leyrolle, Q., Bindels, L. B., Cauduro, C. G. D. S., Mulders, M. D. G. H., Zamariola, G., Azzi, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.04.005 · Cited by 170 · see citing works

Associations between gut microbiota and weight loss in an energy-restricted dietary intervention trial in adults with elevated adiposity

Choo, J. M., Carter, S., Hill, A. M., Sims, S. K., Yandell, C. A., Buckley, J., Tan, S.-Y., Coates, A. S., & Rogers, G. B. (2025) · Proceedings of The Nutrition Society · doi:10.1017/s0029665125001016